LAUSR

Combining STAT3-Targeting Agents with Immune Checkpoint Inhibitors in NSCLC

Sign Up to like & get
recommendations!
2 Published in 2023 at "Cancers"

DOI: 10.3390/cancers15020386

Abstract: Simple Summary Signal transducer and activator of transcription 3 (STAT3) plays a critical role in the development and progression of non-small cell lung cancer (NSCLC) tumors. Several reports suggest that STAT3 is involved in immunosuppression… read more here.

Keywords: combining stat3; resistance immune; checkpoint inhibitors; immune checkpoint ... See more keywords